Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tetradecylacetate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octyl Acetate SCHEMBL27849660 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRNAAAMAPTEPHX1 | |
| Acetic Acid Pentyl Ester SCHEMBL27685689 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TSHRNAAAMAPTEPHX1 | |
| Hexyl Acetate SCHEMBL896029 | 0.93 | ALDH1A1 (0.53) | ALDH1A1TSHRNAAAMAPTEPHX1 | |
| Tetradecylacetate SCHEMBL466058 | 0.93 | ALDH1A1 (0.53) | ALDH1A1TSHRNAAAMAPTEPHX1 | |
| Acetic Acid Butyl Ester SCHEMBL2700544 | 0.92 | ALDH1A1 (0.72) | ALDH1A1TSHRMAPTKDM4EDUSP3 | |
| Acetic Acid Pentyl Ester SCHEMBL27678839 | 0.91 | ALDH1A1 (0.60) | ALDH1A1TSHRNAAAMAPTEPHX1 | |
| Acetic Acid Pentyl Ester SCHEMBL2269446 | 0.91 | ALDH1A1 (0.55) | ALDH1A1TSHRNAAAMAPTEPHX1 | |
| Hexyl Acetate SCHEMBL27795514 | 0.89 | ALDH1A1 (0.61) | ALDH1A1TSHRNAAAEPHX1USP2 | |
| Acetic Acid Butyl Ester SCHEMBL28255898 | 0.89 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPTKDM4EDUSP3 | |
| Acetic Acid Pentyl Ester SCHEMBL27737254 | 0.88 | ALDH1A1 (0.71) | ALDH1A1TSHRNAAAMAPTEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3242687-B1 | NANOPARTICLES AND METHODS FOR PREPARATION THEREOF | B G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV (IL) | 2020-12-30 | — | — | EP | claimed |
| US-20180104347-A1 | NANOPARTICLES AND METHODS FOR PREPARATION THEREOF | B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD. AT BEN-GURION UNIVERSITY (IL) | 2018-04-19 | — | — | US | claimed |
| EP-3242687-A1 | NANOPARTICLES AND METHODS FOR PREPARATION THEREOF | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University (IL) | 2017-11-15 | — | — | EP | claimed |
| WO-2016110839-A1 | NANOPARTICLES AND METHODS FOR PREPARATION THEREOF | B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) | 2016-07-14 | — | — | WO | claimed |
| US-20100034880-A1 | PHARMACEUTICAL COMPOSITIONS BASED ON A MICROEMULSION | NANODERMA LTD (IL) | 2010-02-11 | — | — | US | claimed |
| EP-2120863-A1 | PHARMACEUTICAL COMPOSITIONS BASED ON A MICROEMULSION | Nanoderma Ltd. (IL) | 2009-11-25 | — | — | EP | claimed |
| WO-2008096351-A1 | PHARMACEUTICAL COMPOSITIONS BASED ON A MICROEMULSION | NANODERMA LTD. (IL) | 2008-08-14 | — | — | WO | claimed |
| US-7101563-B1 | Micronized vitamin C formulation | AUSTRALIAN IMPORTERS, LTD. (US) | 2006-09-05 | — | — | US | claimed |
| EP-1558206-A1 | FORMULATIONS FOR TOPICAL DELIVERY OF BIOACTIVE SUBSTANCES AND METHODS FOR THEIR USE | Australian Importers, Ltd (US) | 2005-08-03 | — | — | EP | claimed |
| WO-2004039348-A1 | FORMULATIONS FOR TOPICAL DELIVERY OF BIOACTIVE SUBSTANCES AND METHODS FOR THEIR USE | AUSTRALIAN IMPORTERS, LTD. (US) | 2004-05-13 | — | — | WO | claimed |
| US-20040081681-A1 | Anhydrous formulations for percutaneous absorption | AUSTRALIAN IMPORTERS | 2004-04-29 | — | — | US | claimed |
| EP-4727581-A2 | PHARMACEUTICAL COMPOSITIONS FOR TARGETED DELIVERY OF BIOACTIVE AGENTS WITH IMPROVED BIOAVAILABILITY AND METHODS OF USE | Shapiro, Scott (US) | 2026-04-22 | — | — | EP | disclosed |
| US-12453753-B2 | Oxygenated cannabis skin therapy compositions and methods for producing the compositions | Pauwels, David (US) | 2025-10-28 | — | — | US | disclosed |
| US-12409121-B2 | Formulations and methods for preparing stable cosmetic compositions | Spinart, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| WO-2024259323-A2 | PHARMACEUTICAL COMPOSITIONS FOR TARGETED DELIVERY OF BIOACTIVE AGENTS WITH IMPROVED BIOAVAILABILITY AND METHODS OF USE | SHAPIRO SCOTT (US) | 2024-12-19 | — | — | WO | disclosed |
| EP-0522618-A1 | Coloured cosmetic sticks | UNILEVER N.V. (NL) | 1993-01-13 | — | — | EP | disclosed |
| US-5176902-A | Esterified wax, aluminum lake dye | ELIZABETH ARDEN COMPANY, DIVISION OF CONOPCO, INC. (US) | 1993-01-05 | — | — | US | disclosed |
| EP-0520550-A2 | Method and article for distinguishing cosmetic sticks containing water | UNILEVER N.V. (NL) | 1992-12-30 | — | — | EP | disclosed |
| US-5108737-A | Colored cosmetic sticks | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1992-04-28 | — | — | US | disclosed |
| US-5085856-A | Containing water, waxes, oils to provide moisturisation, protection | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1992-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12453753-B2 | Oxygenated cannabis skin therapy compositions and methods for producing the compositions | CNR2, OXER1, CNR1 | ALDH1A1 2357/4885TSHR 4018/4885NAAA 888/4885 |
| US-12409121-B2 | Formulations and methods for preparing stable cosmetic compositions | CUTA, ARG1, ODC1 | ALDH1A1 2381/4885TSHR 3384/4885NAAA 1476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.